학술논문
Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience
Document Type
Article
Author
Source
In: Cancer Chemotherapy and Pharmacology . (Cancer Chemotherapy and Pharmacology, May 2014, 73(5):943-950)
Subject
Language
English
ISSN
14320843
03445704
03445704